Publications by authors named "Angel Manuel-Iniesta"

Claim this Profile
H
Heart rate at presentation of COVID-19: Can SARS-CoV-2 be a cause of dysautonomia?
Andrea Severo Sánchez, Juan R Rey, Ángel Manuel Iniesta, Jose L Merino, Sergio Castrejón-Castrejón

Rev Port Cardiol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacubitril/Valsartan is useful and safe in elderly people with heart failure and reduced ejection fraction. Data from a real-word cohort.
Alberto Esteban-Fernández, Pablo Díez-Villanueva, Lourdes Vicent, Ramón Bover, Manuel Gómez-Bueno

Rev Esp Geriatr Gerontol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan.
Pablo Díez-Villanueva, Lourdes Vicent, Francisco de la Cuerda, Alberto Esteban-Fernández, Manuel Gómez-Bueno

Cardiology· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex Influence on the Efficacy and Safety of Sacubitril/Valsartan.
Lourdes Vicent, Ana Ayesta, Alberto Esteban-Fernández, Manuel Gómez-Bueno, Javier De-Juan

Cardiology· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of sacubitril/valsartan initiated during hospitalization: data from a non-selected cohort.
Juan Carlos López-Azor, Lourdes Vicent, María Jesús Valero-Masa, Alberto Esteban-Fernández, Manuel Gómez-Bueno, Ángel Manuel-Iniesta

ESC Heart Fail· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacubitril/Valsartan in Daily Clinical Practice: Data From a Prospective Registry.
Lourdes Vicent, Alberto Esteban-Fernández, Manuel Gómez-Bueno, Javier De-Juan, Pablo Díez-Villanueva

J Cardiovasc Pharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Profile of a Nonselected Population Treated With Sacubitril/Valsartan Is Different From PARADIGM-HF Trial.
Lourdes Vicent, Alberto Esteban-Fernández, Manuel Gómez-Bueno, Javier De-Juan, Pablo Díez-Villanueva

J Cardiovasc Pharmacol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis